Clinical Trial Update: A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis [Phase 3]

View source ↗

Summary

This report covers a long-term safety extension of ferric citrate in adults with end-stage renal disease on dialysis, part of a Phase 3 program, with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hyperphosphatemia

Drugs mentioned

• Auryxia (ferric citrate)

Snippet

Sponsor: Keryx Biopharmaceuticals | Conditions: End Stage Renal Disease, Kidney Failure | Phase 3 | Status: COMPLETED | Results posted: 2016-07-13